ArteraAI
- 27/03/2023
- Unknown
- $90,000,000
Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer.
Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.
- Industry Hospital & Health Care
- Website https://artera.ai/
- LinkedIn https://www.linkedin.com/company/arteraai/
Related People
Andre EstevaCo Founder
Homepage: andreesteva.com
Publications: andreesteva.com/scholar.html
Twitter: https://twitter.com/andreesteva
Andre Esteva is a researcher and entrepreneur in medical artificial intelligence. He currently serves as CEO of Artera, and was previously Head of Medical AI at Salesforce Research. He has worked at Google Research, Sandia National Labs, GE Healthcare, and has co-founded four companies.
His research efforts have largely focused on medical AI diagnostics and precision medicine. His publications have made the covers of Nature and Nature Medicine, and have been featured in Cell, The Lancet, NeurIPS, and similar venues. These works have been widely covered by the WSJ, Fortune, BBC, The Economist, and hundreds of other news outlets.
He obtained his PhD in Artificial Intelligence at Stanford, where he worked with Jeff Dean, Eric Topol, Sebastian Thrun, Stephen Boyd, and Fei-Fei Li. His research was in deep learning and computer vision, with applications built for dermatology, drug screening, neuroscience, and psychiatry. He finished undergraduate degrees with highest honors in Electrical Engineering and Pure Math from UT-Austin and was awarded Engineering Valedictorian (formally, the Outstanding Scholar-Leader Award).